Parathyroid gland disorder
MONDO:0001223A disease involving the parathyroid gland.
Also known as: disease of parathyroid gland, disease or disorder of parathyroid gland, disorder of parathyroid gland, parathyroid disease, parathyroid gland disease, parathyroid gland disease or disorder, parathyroid gland diseases, parathyroid gland disorder
164 clinical trials for this condition and its sub-types, 14 tagged with Parathyroid gland disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Parathyroid gland disorder
-
Hyperparathyroidism 8 trials · 89 incl. sub-types
4 sub-types
- Primary hyperparathyroidism 23 trials · 56 incl. sub-types Sub-types →
- Hereditary hyperparathyroidism 1 trial · 35 incl. sub-types Sub-types →
- Secondary hyperparathyroidism 19 trials · 32 incl. sub-types Sub-types →
- Tertiary hyperparathyroidism 2 trials
-
Hypoparathyroidism 46 trials · 66 incl. sub-types
3 sub-types
- Hereditary hypoparathyroidism 0 trials · 26 incl. sub-types Sub-types →
- Autoimmune hypoparathyroidism 0 trials · 8 incl. sub-types Sub-types →
- Secondary hypoparathyroidism due to impaired parathormon secretion 0 trials
-
Tumor of parathyroid gland 3 trials · 46 incl. sub-types
3 sub-types
- Familial primary hyperparathyroidism 1 trial · 35 incl. sub-types Sub-types →
- Benign neoplasm of parathyroid gland 0 trials · 6 incl. sub-types Sub-types →
- Malignant tumor of parathyroid gland 2 trials · 6 incl. sub-types Sub-types →
-
Parathyroid hyperplasia 0 trials
Most studied deeper sub-types
-
New daily shot could replace calcium pills for rare hormone disorder
Disease control CompletedThis Phase 3 trial tested a daily injection of TransCon PTH, a synthetic parathyroid hormone, in 84 adults with hypoparathyroidism. The goal was to see if it could help patients maintain normal blood calcium levels while reducing their need for high-dose calcium and vitamin D sup…
Phase 3 • Sponsor: Ascendis Pharma Bone Diseases A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New daily shot could ease rare hormone disorder
Disease control CompletedThis phase 2 trial tested a daily injection called TransCon PTH in 59 adults with hypoparathyroidism, a condition where the body doesn't make enough parathyroid hormone. Participants were randomly assigned to receive either the drug or a placebo for four weeks, followed by an ope…
Phase 2 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New daily shot could free hypoparathyroidism patients from pills
Disease control CompletedThis study tested a daily injection called TransCon PTH in 81 adults with hypoparathyroidism, a condition where the body lacks parathyroid hormone, causing low calcium levels. The goal was to see if the drug could bring calcium levels back to normal and allow patients to stop tak…
Phase 3 • Sponsor: Visen Pharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Glow-in-the-Dark tool may make parathyroid surgery safer and faster
Symptom relief CompletedThis study tested a device called PTeye that uses near-infrared light to help surgeons spot parathyroid glands during surgery for hyperparathyroidism. The goal was to see if it could reduce the number of tissue samples sent to the lab and lower the risk of needing a second surger…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Ultrasound first: could it replace radiation scans for parathyroid patients?
Knowledge-focused CompletedThis study tested whether using ultrasound as the first imaging step before parathyroid surgery can safely reduce the need for radiation-based scans. 99 adults with primary hyperparathyroidism were enrolled. Those with clear ultrasound results went straight to surgery; others had…
Sponsor: Odense University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC